Your browser doesn't support javascript.
loading
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
Galanis, Evanthia; Anderson, S Keith; Miller, C Ryan; Sarkaria, Jann N; Jaeckle, Kurt; Buckner, Jan C; Ligon, Keith L; Ballman, Karla V; Moore, Dennis F; Nebozhyn, Michael; Loboda, Andrey; Schiff, David; Ahluwalia, Manmeet Singh; Lee, Eudocia Q; Gerstner, Elizabeth R; Lesser, Glenn J; Prados, Michael; Grossman, Stuart A; Cerhan, Jane; Giannini, Caterina; Wen, Patrick Y.
Affiliation
  • Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Anderson SK; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Miller CR; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Sarkaria JN; Pathobiology and Translational Science Graduate Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Jaeckle K; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
  • Buckner JC; Department of Neurology, Mayo Clinic, Jacksonville, Minnesota.
  • Ligon KL; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Ballman KV; Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Moore DF; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Nebozhyn M; Department of Internal Medicine, Cancer Center of Kansas, Wichita, Kansas.
  • Loboda A; Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, Pennsylvania.
  • Schiff D; Data Analysis, Informatics & Analysis Department, Merck Research Laboratories, Boston, Massachusetts.
  • Ahluwalia MS; Neuro-Oncology Center, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Lee EQ; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Gerstner ER; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lesser GJ; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
  • Prados M; Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Grossman SA; Department of Neurological Surgery, University of California San Francisco, San Francisco, California.
  • Cerhan J; Department of Oncology, Medicine & Neurosurgery, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Giannini C; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.
  • Wen PY; Department of Pathology, Mayo Clinic, Rochester, Minnesota.
Neuro Oncol ; 20(4): 546-556, 2018 03 27.
Article in En | MEDLINE | ID: mdl-29016887
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Glioblastoma / Chemoradiotherapy Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Glioblastoma / Chemoradiotherapy Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2018 Document type: Article Country of publication: